$4.30
0.39[9.97%]
At close: Apr 18
$4.30
0[0.00%]
After Hours: 4:00PM EDT
Relmada Therapeutics
(NASDAQ:RLMD)Relmada Therapeutics Stock (NASDAQ:RLMD), Earnings Estimates, EPS, and Revenue
Relmada Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS Estimate
$-0.880
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Relmada Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | PM | RLMD | Q1 | -$0.87 | -$0.88 | — | — | $0.00 | — | — | — | Get Alert |
| 03/19/2024 | PM | RLMD | Q4 | -$1.28 | -$0.83 | -$0.84 | -1.20% | $0.00 | — | $0.00 | — | Get Alert |
| 11/08/2023 | PM | RLMD | Q3 | -$1.31 | -$0.91 | -$0.73 | 19.78% | $0.00 | — | $0.00 | — | Get Alert |
| 08/08/2023 | PM | RLMD | Q2 | -$1.33 | -$0.90 | -$0.84 | 6.67% | $0.00 | — | $0.00 | — | Get Alert |
| 05/11/2023 | PM | RLMD | Q1 | -$1.40 | -$0.89 | -$0.87 | 2.25% | $0.00 | — | $0.00 | — | Get Alert |
| 03/23/2023 | PM | RLMD | Q4 | -$1.80 | -$1.33 | -$1.28 | 3.76% | $0.00 | — | $0.00 | — | Get Alert |
| 11/10/2022 | PM | RLMD | Q3 | -$2.44 | -$1.45 | -$1.31 | 9.66% | $0.00 | — | $0.00 | — | Get Alert |
| 08/11/2022 | PM | RLMD | Q2 | -$1.56 | -$1.27 | -$1.33 | -4.72% | $0.00 | — | $0.00 | — | Get Alert |
| 05/05/2022 | PM | RLMD | Q1 | -$1.34 | -$1.27 | -$1.40 | -10.24% | $0.00 | — | $0.00 | — | Get Alert |
| 03/23/2022 | PM | RLMD | Q4 | -$1.28 | -$1.83 | -$1.80 | 1.64% | $0.00 | — | $0.00 | — | Get Alert |
| 11/11/2021 | PM | RLMD | Q3 | -$1.05 | -$1.60 | -$2.44 | -52.50% | $0.00 | — | $0.00 | — | Get Alert |
| 08/10/2021 | PM | RLMD | Q2 | -$0.73 | -$1.47 | -$1.56 | -6.12% | $0.00 | — | $0.00 | — | Get Alert |
| 05/12/2021 | PM | RLMD | Q1 | — | -$1.39 | -$1.34 | 3.60% | — | — | $0.00 | — | Get Alert |
| 03/23/2021 | PM | RLMD | Q4 | — | -$1.16 | -$1.28 | -10.34% | — | — | $0.00 | — | Get Alert |
| 11/12/2020 | PM | RLMD | Q3 | — | — | -$1.05 | — | — | — | $0.00 | — | Get Alert |
| 08/12/2020 | AM | RLMD | Q2 | — | — | -$0.73 | — | — | — | $0.00 | — | Get Alert |
FAQ
When is Relmada Therapeutics (NASDAQ:RLMD) reporting earnings?
Relmada Therapeutics (RLMD) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 19, 2024 for Q4.
What were the latest earnings per share (EPS) for Relmada Therapeutics (NASDAQ:RLMD)?
The Actual EPS was $-0.84, which missed the estimate of $-0.83.
What were Relmada Therapeutics’s (NASDAQ:RLMD) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.